Harbour Investments »

Lexeo Therapeutics shares owned by Harbour Investments

Quarter-by-quarter ownership of Lexeo Therapeutics (LXEO) shares owned by Harbour Investments from 13F filings

Historical chart of Harbour Investments investment in Lexeo Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lexeo Therapeutics held by Harbour Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lexeo Therapeutics by Harbour Investments

Quarter filed Position value Share count Share price at filing
2026-03-31 $5.7k 1.0k 5.74

More positions owned by Harbour Investments

Vanguard S&p 500 Etf Etf (VOO)
Invesco Qqq Trust Series I Etf (QQQ)
First Trust Smid Cap Rising Dividend Achievers Etf Etf (SDVY)
Apple Stock (AAPL)
First Trust Smith Unconstrained Bond Etf Etf (UCON)
Avantis Emerging Markets Equity Etf Etf (AVEM)
Ft Vest Laddered Buffer Etf Etf (BUFR)
Ishares Core S&p Mid-cap Etf Etf (IJH)
Ishares Core S&p 500 Etf Etf (IVV)
Capital Group Core Plus Income Etf Etf (CGCP)
State Street Spdr S&p 500 Etf Etf (SPY)
First Trust Rising Dividend Achievers Etf Etf (RDVY)
Ishares S&p 500 Growth Etf Etf (IVW)
Ishares S&p 500 Value Etf Etf (IVE)
Schwab Us Dividend Equity Etf Etf (SCHD)

View all positions for Harbour Investments

Top funds holding Lexeo Therapeutics

Paradigm Biocapital Advisors
BlackRock
RA Capital Management
Henderson Group
Vestal Point Capital
Frazier Life Sciences Management
Vanguard Group
Citadel Advisors
OrbiMed Advisors
venBio Select Advisor
Affinity Asset Advisors
State Street Corporation
Vanguard Capital Management
Woodline Partners
Goldman Sachs Group

View all funds holding Lexeo Therapeutics